Clinical Test Uses Ips Cells To Treat Cancer
A group of researchers in Japan says it is using immune cells derived from induced pluripotent stem cells, or iPS cells, in a clinical trial for cancer treatment.
The researchers say the clinical test started this month at Chiba University Hospital, near Tokyo, and is the first in the country to apply iPS cells to treat cancer.
- Published in News
- Read more...